Recognizing the Complexities of AHP

In this video, watch a panel of multidisciplinary physicians discuss the reasons why patients afflicted with acute hepatic porphyria (AHP) are often misdiagnosed or remain undiagnosed for up to 15 years. Learn about when they would consider suspecting, testing for and diagnosing AHP.


Moderator: Amy Simon, MD
Vice President, Clinical Research
Alnylam Pharmaceuticals, Inc.
Cambridge, Massachusetts

Srikanth Nagalla, MD
UT Southwestern Medical Center
Dallas, Texas

Bruce Wang, MD
University of California – San Francisco (UCSF)
San Francisco, California

Sponsored by Alnylam Pharmaceuticals, Inc.